Inositol trisphosphate receptor

Last updated
inositol 1,4,5-trisphosphate receptor, type 1 [1]
1XZZ.pdb.jpg
Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor
Identifiers
SymbolITPR1
NCBI gene 3708
HGNC 6180
OMIM 147265
RefSeq NM_002222
UniProt Q14643
Other data
Locus Chr. 3 p26.1
Search for
Structures Swiss-model
Domains InterPro
inositol 1,4,5-trisphosphate receptor, type 2
Identifiers
SymbolITPR2
NCBI gene 3709
HGNC structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor 6181 Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor 6181
OMIM 600144
RefSeq NM_002223
UniProt Q14571
Other data
Locus Chr. 12 p11.23
Search for
Structures Swiss-model
Domains InterPro
inositol 1,4,5-trisphosphate receptor, type 3
IP3 receptor type 3 (ITPR3) - 6DQN.png
Single-particle cryo-EM structure of the IP3-bound resting state.
Identifiers
SymbolITPR3
NCBI gene 3710
HGNC 6182
OMIM 147267
RefSeq NM_002224
UniProt Q14573
Other data
Locus Chr. 6 p21.31
Search for
Structures Swiss-model
Domains InterPro

Inositol trisphosphate receptor (InsP3R) is a membrane glycoprotein complex acting as a Ca2+ channel activated by inositol trisphosphate (InsP3). InsP3R is very diverse among organisms, and is necessary for the control of cellular and physiological processes including cell division, cell proliferation, apoptosis, fertilization, development, behavior, learning and memory. [2] Inositol triphosphate receptor represents a dominant second messenger leading to the release of Ca2+ from intracellular store sites. There is strong evidence suggesting that the InsP3R plays an important role in the conversion of external stimuli to intracellular Ca2+ signals characterized by complex patterns relative to both space and time, such as Ca2+ waves and oscillations. [3]

Contents

Discovery

The InsP3 receptor was first purified from rat cerebellum by neuroscientists Surachai Supattapone and Solomon Snyder at Johns Hopkins University School of Medicine. [4]

The cDNA of the InsP3 receptor was first cloned in the laboratory of Katsuhiko Mikoshiba. The initial sequencing was reported as an unknown protein enriched in the cerebellum called P400. [5] The large size of this open reading frame indicated a molecular weight similar to the protein purified biochemically, and soon thereafter it was confirmed that the protein p400 was in fact the inositol trisphosphate receptor. [6]

Distribution

The receptor has a broad tissue distribution but is especially abundant in the cerebellum. Most of the InsP3Rs are found integrated into the endoplasmic reticulum.

Structure

Several X-ray crystallographic [7] [8] [9] and electron cryomicroscopic (cryo-EM) [10] [11] [12] [13] [14] [15] [16] structures of IP3Rs from mouse, rat, and human have defined the overall architecture of the channel. The 1.2 MDa C4-symmetric assembly consists of an ER-embedded transmembrane domain (TMD) in a domain-swapped 6 transmembrane (6TM) cation channel fold that is capped by a large cytosolic domain (CD). In this manner, IP3Rs share significant homology with the much larger and distantly-related RyRs. [17] The CD contains all known ligand binding sites, including the IP3 binding site, two Ca2+ binding sites, an adenine nucleotide binding site, and a C2H2 Zn2+ finger fold. A comprehensive Ca2+-dependent conformational landscape has recently been defined by cryo-EM. [18]

See also

Related Research Articles

<span class="mw-page-title-main">G protein-coupled receptor</span> Class of cell surface receptors coupled to G-Protein associated intracelular signaling

G protein-coupled receptors (GPCRs), also known as seven-(pass)-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptors, and G protein-linked receptors (GPLR), form a large group of evolutionarily related proteins that are cell surface receptors that detect molecules outside the cell and activate cellular responses. Since they are coupled with G proteins, they pass through the cell membrane seven times in form of six loops of amino acid residues, which is why they are sometimes referred to as seven-transmembrane receptors. Ligands can bind either to the extracellular N-terminus and loops or to the binding site within transmembrane helices. They are all activated by agonists, although a spontaneous auto-activation of an empty receptor has also been observed.

Inositol trisphosphate or inositol 1,4,5-trisphosphate abbreviated InsP3 or Ins3P or IP3 is an inositol phosphate signaling molecule. It is made by hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid that is located in the plasma membrane, by phospholipase C (PLC). Together with diacylglycerol (DAG), IP3 is a second messenger molecule used in signal transduction in biological cells. While DAG stays inside the membrane, IP3 is soluble and diffuses through the cell, where it binds to its receptor, which is a calcium channel located in the endoplasmic reticulum. When IP3 binds its receptor, calcium is released into the cytosol, thereby activating various calcium regulated intracellular signals.

Ryanodine receptors form a class of intracellular calcium channels in various forms of excitable animal tissue like muscles and neurons. There are three major isoforms of the ryanodine receptor, which are found in different tissues and participate in different signaling pathways involving calcium release from intracellular organelles. The RYR2 ryanodine receptor isoform is the major cellular mediator of calcium-induced calcium release (CICR) in animal cells.

<span class="mw-page-title-main">Inositol phosphate</span>

Inositol phosphates are a group of mono- to hexaphosphorylated inositols. They play crucial roles in diverse cellular functions, such as cell growth, apoptosis, cell migration, endocytosis, and cell differentiation. The group comprises:

<span class="mw-page-title-main">Phosphatidylinositol (3,4,5)-trisphosphate</span> Chemical compound

Phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3), abbreviated PIP3, is the product of the class I phosphoinositide 3-kinases (PI 3-kinases) phosphorylation of phosphatidylinositol (4,5)-bisphosphate (PIP2). It is a phospholipid that resides on the plasma membrane.

<span class="mw-page-title-main">Phosphatidylinositol 4,5-bisphosphate</span> Chemical compound

Phosphatidylinositol 4,5-bisphosphate or PtdIns(4,5)P2, also known simply as PIP2 or PI(4,5)P2, is a minor phospholipid component of cell membranes. PtdIns(4,5)P2 is enriched at the plasma membrane where it is a substrate for a number of important signaling proteins. PIP2 also forms lipid clusters that sort proteins.

<span class="mw-page-title-main">Adenophostin</span> Chemical compound

Adenophostin A is a potent inositol trisphosphate (IP3) receptor agonist, but is much more potent than IP3.

The formyl peptide receptors (FPR) belong to a class of G protein-coupled receptors involved in chemotaxis. In humans, there are three formyl peptide receptor isoforms, each encoded by a separate gene that are named FPR1, FPR2, and FPR3. These receptors were originally identified by their ability to bind N-formyl peptides such as N-formylmethionine produced by the degradation of either bacterial or host cells. Hence formyl peptide receptors are involved in mediating immune cell response to infection. These receptors may also act to suppress the immune system under certain conditions. The close phylogenetic relation of signaling in chemotaxis and olfaction was recently proved by detection formyl peptide receptor like proteins as a distinct family of vomeronasal organ chemosensors in mice.

<span class="mw-page-title-main">2-Aminoethoxydiphenyl borate</span> Chemical compound

2-Aminoethoxydiphenyl borate (2-APB) is a chemical that acts to inhibit both IP3 receptors and TRP channels (although it activates TRPV1, TRPV2, & TRPV3 at higher concentrations). In research it is used to manipulate intracellular release of calcium ions (Ca2+) and modify TRP channel activity, although the lack of specific effects make it less than ideal under some circumstances. Additionally, there is evidence that 2-APB acts directly to inhibit gap junctions made of connexin. Increasing evidence showed that 2-APB is a powerful modifier of store-operated calcium channels (SOC) function, low concentration of 2-APB can enhance SOC while high concentration induces a transient increase followed by complete inhibition.

<span class="mw-page-title-main">ITPKB</span> Protein-coding gene in the species Homo sapiens

Inositol-trisphosphate 3-kinase B is an enzyme that in humans is encoded by the ITPKB gene.

<span class="mw-page-title-main">ITPR1</span>

Inositol 1,4,5-trisphosphate receptor type 1 is a protein that in humans is encoded by the ITPR1 gene.

<span class="mw-page-title-main">GPR75</span> Protein-coding gene in the species Homo sapiens

Probable G-protein coupled receptor 75 is a protein that in humans is encoded by the GPR75 gene.

<span class="mw-page-title-main">Inositol-trisphosphate 3-kinase</span> Class of enzymes

Inositol (1,4,5) trisphosphate 3-kinase (EC 2.7.1.127), abbreviated here as ITP3K, is an enzyme that facilitates a phospho-group transfer from adenosine triphosphate to 1D-myo-inositol 1,4,5-trisphosphate. This enzyme belongs to the family of transferases, specifically those transferring phosphorus-containing groups (phosphotransferases) with an alcohol group as acceptor. The systematic name of this enzyme class is ATP:1D-myo-inositol-1,4,5-trisphosphate 3-phosphotransferase. ITP3K catalyzes the transfer of the gamma-phosphate from ATP to the 3-position of inositol 1,4,5-trisphosphate to form inositol 1,3,4,5-tetrakisphosphate. ITP3K is highly specific for the 1,4,5-isomer of IP3, and it exclusively phosphorylates the 3-OH position, producing Ins(1,3,4,5)P4, also known as inositol tetrakisphosphate or IP4.

<span class="mw-page-title-main">ITPKA</span>

Inositol-trisphosphate 3-kinase A is an enzyme that in humans is encoded by the ITPKA gene.

<span class="mw-page-title-main">Calcium-binding protein 1</span>

Calcium binding protein 1 is a protein that in humans is encoded by the CABP1 gene. Calcium-binding protein 1 is a calcium-binding protein discovered in 1999. It has two EF hand motifs and is expressed in neuronal cells in such areas as hippocampus, habenular nucleus of the epithalamus, Purkinje cell layer of the cerebellum, and the amacrine cells and cone bipolar cells of the retina.

<span class="mw-page-title-main">AHCYL1</span> Protein-coding gene in the species Homo sapiens

Putative adenosylhomocysteinase 2 is an enzyme that in humans is encoded by the AHCYL1 gene.

<span class="mw-page-title-main">ITPK1</span>

Inositol-tetrakisphosphate 1-kinase is an enzyme that in humans is encoded by the ITPK1 gene.

<span class="mw-page-title-main">ITPR2</span>

Inositol 1,4,5-trisphosphate receptor, type 2, also known as ITPR2, is a protein which in humans is encoded by the ITPR2 gene. The protein encoded by this gene is both a receptor for inositol triphosphate and a calcium channel.

<span class="mw-page-title-main">ITPR3</span>

Inositol 1,4,5-trisphosphate receptor, type 3, also known as ITPR3, is a protein which in humans is encoded by the ITPR3 gene. The protein encoded by this gene is both a receptor for inositol triphosphate and a calcium channel.

The ryanodine-inositol 1,4,5-triphosphate receptor Ca2+ channel (RIR-CaC) family includes Ryanodine receptors and Inositol trisphosphate receptors. Members of this family are large proteins, some exceeding 5000 amino acyl residues in length. This family belongs to the Voltage-gated ion channel (VIC) superfamily. Ry receptors occur primarily in muscle cell sarcoplasmic reticular (SR) membranes, and IP3 receptors occur primarily in brain cell endoplasmic reticular (ER) membranes where they effect release of Ca2+ into the cytoplasm upon activation (opening) of the channel. They are redox sensors, possibly providing a partial explanation for how they control cytoplasmic Ca2+. Ry receptors have been identified in heart mitochondria where they provide the main pathway for Ca2+ entry. Sun et al. (2011) have demonstrated oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel (RyR1;TC# 1.A.3.1.2) by NADPH oxidase 4.

References

  1. Bosanac I, Yamazaki H, Matsu-Ura T, Michikawa T, Mikoshiba K, Ikura M (January 2005). "Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor". Molecular Cell. 17 (2): 193–203. doi: 10.1016/j.molcel.2004.11.047 . PMID   15664189.
  2. Bosanac I, Alattia JR, Mal TK, Chan J, Talarico S, Tong FK, et al. (December 2002). "Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand". Nature. 420 (6916): 696–700. Bibcode:2002Natur.420..696B. doi:10.1038/nature01268. PMID   12442173. S2CID   4422308.
  3. Yoshida Y, Imai S (June 1997). "Structure and function of inositol 1,4,5-trisphosphate receptor". Japanese Journal of Pharmacology. 74 (2): 125–137. doi: 10.1254/jjp.74.125 . PMID   9243320.
  4. Supattapone S, Worley PF, Baraban JM, Snyder SH (January 1988). "Solubilization, purification, and characterization of an inositol trisphosphate receptor". The Journal of Biological Chemistry. 263 (3): 1530–1534. doi: 10.1016/S0021-9258(19)57336-7 . PMID   2826483.
  5. Furuichi T, Yoshikawa S, Mikoshiba K (July 1989). "Nucleotide sequence of cDNA encoding P400 protein in the mouse cerebellum". Nucleic Acids Research. 17 (13): 5385–5386. doi:10.1093/nar/17.13.5385. PMC   318125 . PMID   2762133.
  6. Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N, Mikoshiba K (November 1989). "Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400". Nature. 342 (6245): 32–38. Bibcode:1989Natur.342...32F. doi:10.1038/342032a0. PMID   2554142. S2CID   1781700.
  7. Bosanac I, Alattia JR, Mal TK, Chan J, Talarico S, Tong FK, et al. (December 2002). "Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand". Nature. 420 (6916): 696–700. Bibcode:2002Natur.420..696B. doi:10.1038/nature01268. PMID   12442173. S2CID   4422308.
  8. Lin CC, Baek K, Lu Z (September 2011). "Apo and InsP₃-bound crystal structures of the ligand-binding domain of an InsP₃ receptor". Nature Structural & Molecular Biology. 18 (10): 1172–1174. doi:10.1038/nsmb.2112. PMC   3242432 . PMID   21892169.
  9. Seo MD, Velamakanni S, Ishiyama N, Stathopulos PB, Rossi AM, Khan SA, et al. (January 2012). "Structural and functional conservation of key domains in InsP3 and ryanodine receptors". Nature. 483 (7387): 108–112. Bibcode:2012Natur.483..108S. doi:10.1038/nature10751. PMC   3378505 . PMID   22286060.
  10. Fan G, Baker ML, Wang Z, Baker MR, Sinyagovskiy PA, Chiu W, et al. (November 2015). "Gating machinery of InsP3R channels revealed by electron cryomicroscopy". Nature. 527 (7578): 336–341. Bibcode:2015Natur.527..336F. doi:10.1038/nature15249. PMC   4804758 . PMID   26458101.
  11. Paknejad N, Hite RK (August 2018). "Structural basis for the regulation of inositol trisphosphate receptors by Ca2+ and IP3". Nature Structural & Molecular Biology. 25 (8): 660–668. doi:10.1038/s41594-018-0089-6. PMC   6082148 . PMID   30013099.
  12. Fan G, Baker MR, Wang Z, Seryshev AB, Ludtke SJ, Baker ML, Serysheva II (December 2018). "Cryo-EM reveals ligand induced allostery underlying InsP3R channel gating". Cell Research. 28 (12): 1158–1170. doi:10.1038/s41422-018-0108-5. PMC   6274648 . PMID   30470765.
  13. Azumaya CM, Linton EA, Risener CJ, Nakagawa T, Karakas E (February 2020). "Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist". The Journal of Biological Chemistry. 295 (6): 1743–1753. doi: 10.1074/jbc.RA119.011570 . PMC   7008357 . PMID   31915246.
  14. Baker MR, Fan G, Seryshev AB, Agosto MA, Baker ML, Serysheva II (May 2021). "Cryo-EM structure of type 1 IP3R channel in a lipid bilayer". Communications Biology. 4 (1): 625. doi:10.1038/s42003-021-02156-4. PMC   8149723 . PMID   34035440.
  15. Schmitz EA, Takahashi H, Karakas E (March 2022). "Structural basis for activation and gating of IP3 receptors". Nature Communications. 13 (1): 1408. Bibcode:2022NatCo..13.1408S. doi:10.1038/s41467-022-29073-2. PMC   8930994 . PMID   35301323.
  16. Fan G, Baker MR, Terry LE, Arige V, Chen M, Seryshev AB, et al. (November 2022). "Conformational motions and ligand-binding underlying gating and regulation in IP3R channel". Nature Communications. 13 (1): 6942. Bibcode:2022NatCo..13.6942F. doi:10.1038/s41467-022-34574-1. PMC   9663519 . PMID   36376291.
  17. Woll KA, Van Petegem F (January 2022). "Calcium-release channels: structure and function of IP3 receptors and ryanodine receptors". Physiological Reviews. 102 (1): 209–268. doi: 10.1152/physrev.00033.2020 . PMID   34280054. S2CID   236141016.
  18. Paknejad N, Sapuru V, Hite RK (2022-12-30). "Structural titration reveals Ca2+-dependent conformational landscape of the IP3receptor". bioRxiv. doi:10.1101/2022.12.29.522241. S2CID   255373875.